AP NEWS
ADVERTISEMENT
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Urinary Tract Infection Treatment Market Research 2020-2024 | Industry Analysis for the New Normal | Technavio

December 29, 2020 GMT
Technavio has announced its latest market research report titled Global Urinary Tract Infection (UTI) Treatment Market 2020-2024 (Graphic: Business Wire)
Technavio has announced its latest market research report titled Global Urinary Tract Infection (UTI) Treatment Market 2020-2024 (Graphic: Business Wire)

LONDON--(BUSINESS WIRE)--Dec 29, 2020--

The urinary tract infection treatment market is poised to grow by USD 786.71 million during 2020-2024, progressing at a CAGR of almost 2% during the forecast period.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005433/en/

ADVERTISEMENT

Technavio has announced its latest market research report titled Global Urinary Tract Infection (UTI) Treatment Market 2020-2024 (Graphic: Business Wire)

Worried about the impact of COVID-19 on your business? Here is an exclusive report talking about Market scenarios, Estimates, The impact of lockdown, and Customer behavior.

Get FREE Sample Report in Minutes!

The report on the urinary tract infection treatment market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the relation of UTI with several other factors leading to the rising incidence rate of UTI.

The urinary tract infection treatment market analysis includes disease type, geography, and key vendors. This study identifies the growing awareness of controlled usage of antibiotics as one of the prime reasons driving the urinary tract infection treatment market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The urinary tract infection treatment market covers the following areas:

ADVERTISEMENT

Urinary Tract Infection Treatment Market Sizing

Urinary Tract Infection Treatment Market Forecast

Urinary Tract Infection Treatment Market Analysis

Companies Mentioned

  • Abbott Laboratories
  • AbbVie Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • SHIONOGI Co. Ltd.

Related Reports onHealth CareInclude:

Global Upper Respiratory Tract Infection Treatment Market - The upper respiratory tract infection treatment market is segmented by type (antibiotics, NSAIDs and nasal decongestants, and others) and geography (North America, Europe, Asia, and ROW). Click Here to Get an Exclusive Free Sample Report

Global Clostridium Difficile Treatment Market - The clostridium difficile (CDI) treatment market is segmented by product (broad-spectrum antibiotics and narrow-spectrum antibiotics) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Disease type

  • Market segments
  • Comparison by Disease type
  • Uncomplicated UTI - Market size and forecast 2019-2024
  • Complicated UTI - Market size and forecast 2019-2024
  • Market opportunity by Disease type

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Asia - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • AbbVie Inc.
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • SHIONOGI Co. Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

View source version on businesswire.com:https://www.businesswire.com/news/home/20201229005433/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email:media@technavio.com

Website:www.technavio.com/

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Technavio Research

Copyright Business Wire 2020.

PUB: 12/29/2020 04:34 PM/DISC: 12/29/2020 04:34 PM

http://www.businesswire.com/news/home/20201229005433/en